From: Presence of gustatory and olfactory dysfunction in the time of the COVID-19 pandemic
Variable | COVID-19 Positive | COVID-19 Negative | p-value |
---|---|---|---|
Use of anti-inflammatory medication | 26 (60.4%) | 245 (36.68%) | 0.0019 |
Ibuprofen | 11 (25.6%) | 137 (20.5%) | 0.4271 |
Acetaminophen | 13 (30.2%) | 90 (13.5%) | 0.0025 |
Aspirin | 1 (2.3%) | 25 (3.7%) | 1.0000 |
Metamizole | 6 (14.0%) | 21 (3.1%) | 0.0039 |
Diclofenac | 1 (2.3%) | 1 (0.1%) | 0.1174 |
Other medication | 2 (4.7%) | 29 (4.3%) | 0.0027 |